[Anti-Xa activity during administration of low-molecular weight heparin in the prevention of postoperative thromboembolic complications]

Rozhl Chir. 1999 Dec;78(12):618-21.
[Article in Czech]

Abstract

The authors evaluate the follow-up of the anti-Xa level during the prophylactic administration of two different low molecular heparins (enoxaparin, reviparin) in 40 patients with a planned resection of the large intestine, resection of the pancreas, laparoscopic cholecystectomy and laparotomic cholecystectomy. The assessed amounts of anti-Xa did not reach recommended levels even during the perioperative period. The selection of the preparation and the extent of the operation did not influence the anti-Xa levels.

MeSH terms

  • Adult
  • Enoxaparin / therapeutic use*
  • Factor Xa Inhibitors*
  • Fibrinolytic Agents / therapeutic use*
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Middle Aged
  • Postoperative Complications / prevention & control*
  • Thromboembolism / etiology
  • Thromboembolism / prevention & control*

Substances

  • Enoxaparin
  • Factor Xa Inhibitors
  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • reviparin